Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)
Listen to this Section


$1.92
+0.0150 ( +0.79% ) 1.2M

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Clinical Trial Pipeline Stages


Drug Name Stage
INPEFA™ (SOTAGLIFLOZIN)DetailsHeart disease, Heart failure Approved
XERMELO® (telotristat ethyl)DetailsCarcinoid syndrome diarrhea Approved
ZYNQUISTA™ (sotagliflozin)DetailsHypertrophic cardiomyopathies Phase 3
LX9211DetailsNeuropathy, Diabetic peripheral neuropathy Phase 2b
ZYNQUISTA™ (sotagliflozin)DetailsType 1 diabetes, Diabetes Failed

Market Data


Open $1.92
Previous Close $1.90
Volume 1.2M
Market Cap $821.76M
Day Range $1.84 - $1.97
52 Week Range $0.64 - $2.53
Shares Outstanding 444.20M
Change % +0.79%
Net Change ▲ 0.0150
Insider Ownership -0.06%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2000
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -63,152,917.00

Date Type Amount Purchased Purchaser
2024-08-12 Sale -200000.00 Corrigan Brian
2024-07-08 Sale -1675000.00 Exton Michael
2024-07-08 Sale -307000.00 WADE JEFFREY L
2024-05-14 Sale -57546100.00 Artal International S.C.A.
2024-05-13 Sale -44906.00 LEFKOWITZ ROBERT J MD
2024-05-13 Sale -44906.00 Sullivan Diane E.
2024-05-13 Sale -44906.00 SOBECKI CHRISTOPHER J
2024-05-13 Sale -44906.00 BARKER SAM L
2024-05-13 Sale -44906.00 Swain Judith L
2024-05-13 Sale -44906.00 Amouyal Philippe

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 10, 2025
10-q Quarterly Reports 57 Nov 06, 2025
8-k 8K-related 15 Nov 06, 2025
8-k 8K-related 13 Nov 06, 2025
10-q Quarterly Reports 57 Aug 06, 2025
8-k 8K-related 13 Aug 06, 2025
8-k 8K-related 12 Jul 28, 2025
8-k 8K-related 12 Jul 03, 2025
3 Insider transactions 1 Jun 09, 2025
3 Insider transactions 1 Jun 06, 2025

Latest News


× Before browsing our site, please accept our cookies policy